Related Experiment Video

Updated: May 15, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Molecular features related to the binding mode of PPARδ agonists from QSAR and docking analyses

T S Garcia1, D C Silva, J C Gertrudes

  • 1School of Arts, Sciences and Humanities, University of São Paulo, São Paulo, Brazil.

SAR and QSAR in Environmental Research
|January 4, 2013
PubMed

Insights

Molecular modeling reveals key factors for activating peroxisome proliferator-activated receptors (PPARs), crucial targets for treating diabetes and metabolic syndrome. This research aids in designing improved therapeutic compounds.

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Pharmacology

Background:

  • Diabetes mellitus and metabolic syndrome affect a significant global population, often linked to obesity.
  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate carbohydrate and lipid metabolism.
  • PPARs represent a promising therapeutic target for metabolic disorders.

Purpose of the Study:

  • To elucidate the molecular determinants of PPARδ activation using computational modeling.
  • To develop quantitative structure-activity relationship (QSAR) models for PPARδ agonists.
  • To guide the design of novel compounds with enhanced biological activity.

Main Methods:

  • Quantitative Structure-Activity Relationship (QSAR) modeling.
  • 3D-Quantitative Structure-Activity Relationship (3D-QSAR) analysis, including CoMFA.
  • Molecular modeling and analysis of receptor-ligand interactions.

Main Results:

  • Developed robust QSAR and HQSAR models with high predictive accuracy (q²=0.83, r²=0.87 and q²=0.73, r²=0.90, respectively).
  • Generated a highly validated CoMFA model (q²=0.88, r²=0.94), indicating strong predictive power.
  • Identified key molecular properties and interactions influencing PPARδ agonism through contour maps.

Conclusions:

  • The study successfully established reliable QSAR models for PPARδ.
  • Molecular modeling insights provide a foundation for designing new PPARδ agonists.
  • Findings facilitate the development of improved therapeutic agents for diabetes and metabolic syndrome.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.